Document:

ARO-20140314-Exhibit10.1

Exhibit 10.1

AMENDMENT TO RIGHTS AGREEMENT
by and between
AÉROPOSTALE, INC.
and
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC, 
as Rights Agent
_________________
Dated as of
March 13, 2014

US_ACTIVE:\44444328\2\11727.0008

AMENDMENT TO RIGHTS AGREEMENT
THIS AMENDMENT TO RIGHTS AGREEMENT (this “Amendment”), dated as of March 13, 2014, is entered into by and between Aéropostale, Inc., a Delaware corporation (the “Corporation”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Rights Agent”).
RECITALS
WHEREAS, on November 26, 2013, the board of directors of the Corporation authorized the issuance of, and declared a dividend payable in, one right (a “Right”) for each share of common stock, par value $0.01 per share, of the Corporation outstanding as of close of business on December 9, 2013, having the rights and preferences set forth in the Certificate of Designations filed with the Secretary of State of the State of Delaware on November 26, 2013; 
WHEREAS, in connection therewith, the Corporation and the Rights Agent entered into a Rights Agreement, dated November 26, 2013 (the “Rights Agreement”), which set forth the terms and conditions of such Rights; and
WHEREAS, in accordance with Section 26 of the Rights Agreement, the parties desire to amend certain provisions of the Rights Agreement as set forth in this Amendment.
NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:
Section 1.Definitions.  Capitalized terms used but not defined in this Amendment have the meaning ascribed to such terms in the Rights Agreement.
Section 2.Amendment to Rights Agreement.  Subject to the terms and conditions of this Amendment, the definition of “Existing Holder” set forth in Section 1(n) of the Rights Agreement is hereby amended and restated in its entirety as follows:
“(n)    “Existing Holder” shall mean (i) Lemur LLC, together with its Affiliates and Associates; provided, however, that Lemur LLC and its Affiliates and Associates shall not be deemed to be an “Acquiring Person” pursuant to Section 1(a)(ii) of the Rights Agreement with respect to the acquisition and issuance of Series B Convertible Preferred Stock pursuant to the terms of the Stock Purchase and Investor Rights Agreement Summary of Terms and Conditions dated March 13, 2014 or any definitive agreement relating thereto (and any subsequent issuance of common stock of the Corporation as a result of the conversion thereof) and (ii) any Person who, together with its Affiliates and Associates, as of 5:00 p.m. New York City time on November 25, 2013, is the Beneficial Owner of 

US_ACTIVE:\44444328\2\11727.0008

ten percent (10%) (fifteen percent (15%) in the case of a Passive Institutional Investor) or more of the Voting Stock then outstanding.”
Section 3.No Other Amendments.  All terms and conditions of the Rights Agreement not expressly modified by this Amendment remain in full force and effect and unchanged.
Section 4.Governing Law.  This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed and enforced in accordance with the laws of such state applicable to contracts to be made and performed entirely within such state.
Section 5.Counterparts.  This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.
Section 6.Descriptive Headings.  Descriptive headings of the several Sections of this Amendment are inserted for convenience only and shall not control or affect the meaning or construction of any of the provisions hereof.    
[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]

2

    
US_ACTIVE:\44444328\2\11727.0008

            

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed, all as of the day and year first above written.
            
	
		
	 
	AÉROPOSTALE, INC.

	 
	 

	 
	 

	 
	 

	 
	By: /s/ Marc G. Schuback

	 
	Name: Marc G. Schuback

	 
	Title: Senior Vice President, General Counsel & Secretary 

	 
	 

	 
	 

	 
	 

	 
	 

	 
	AMERICAN STOCK TRANSFER &

	 
	TRUST COMPANY, LLC, as Rights Agent

	 
	 

	 
	 

	 
	 

	 
	By: /s/ Paula Caroppoli

	 
	Name: Paula Caroppoli

	 
	Title: Senior Vice President

	 
	 

[SIGNATURE PAGE TO AMENDMENT TO RIGHTS AGREEMENT]exh_1020.htm

Exhibit 10.20

 

Director Compensation Arrangements

 

Compensation of Non-Employee Directors Upon Initial Election to the Board

 

Each non-employee director will be entitled to receive a non-qualified stock option to purchase 30,000 shares of common stock of the Corporation vesting annually over three years and granted on the fifth business day following his or her initial election to the Board.

 

Annual Compensation of Non-Employee Directors

 

Each non-employee director will be entitled to receive an annual retainer in the amount of $35,000 paid in four equal quarterly installments. The Chairman will also be entitled to receive an additional annual retainer of $35,000 paid in four equal quarterly installments. Each non-employee director member of the Audit Committee will be entitled to receive an additional annual retainer of $9,000 paid in four equal quarterly installments. Each non-employee director member of the Compensation Committee will be entitled to receive an additional annual retainer of $6,000 paid in four equal quarterly installments. Each non-employee member of the Governance Committee will be entitled to receive an additional annual retainer of $4,000 paid in four equal quarterly installments. The Committee Chairman of the Audit Committee will be entitled to receive an additional annual retainer of $18,000 paid in four equal quarterly installments.  The Committee Chairman of the Compensation Committee will be entitled to receive an additional annual retainer of $12,000 paid in four equal quarterly installments.  The Committee Chairman of the Governance Committee will be entitled to receive an additional annual retainer of $4,000 paid in four equal quarterly installments.  Each non-employee director will also be entitled to receive an equity award having an aggregate Black-Scholes cash value of $60,000, rounded to the nearest 100 shares, vesting fully one year from the date of grant  and granted on the fifth business day following the Corporation’s Annual Meeting of Stockholders, with such award to be evidenced by a grant of a non-qualified common stock option covering half of the value of the award and deferred stock awards of restricted stock units covering the remaining half.  In addition, non-employee directors shall be reimbursed for their expenses incurred in connection with attending Board and Committee meetings.exh_1021.htm

Exhibit 10.21

AMENDMENT NO. 1 TO THE HARVARD BIOSCIENCE, INC.

EMPLOYEE STOCK PURCHASE PLAN

WHEREAS, the Board of Directors of Harvard Bioscience, Inc.  (“Company”) adopted the Harvard Bioscience, Inc. Employee Stock Purchase Plan (“Plan”) on October 26, 2000; and

WHEREAS, the Plan is intended to constitute an “employee stock purchase plan”  within the meaning of Section 423 (b) of the Internal Revenue Code of 1986, as amended (“Plan“); and

WHEREAS, the Company desires to amend the Plan in accordance with Section 18 thereof;

NOW, THEREFORE, the Company hereby amends the definition of Compensation in its entirety as it appears in the first paragraph of Section 11 of the Plan effective as of January 1, 2012,  as follows:

“The term, “Compensation” means the amount of an employee’s  base pay from the Company prior to any reduction for deferrals made under either Code Section 125 or 401(k), including commissions, but excluding overtime, incentive or  bonus awards, allowances and reimbursements for expenses such as relocation allowances or travel expenses, income or gains on the exercise of Company stock options, and similar extraordinary items.”exh_1022.htm

Exhibit 10.22

FIRST AMENDMENT TO

HARVARD BIOSCIENCE, INC.

THIRD AMENDED AND RESTATED 2000 STOCK OPTION AND INCENTIVE PLAN

This First Amendment to the Harvard Bioscience, Inc. Third Amended and Restated 2000 Stock Option and Incentive Plan (the “Plan”) is effective as of March 9, 2013 (the “Effective Date”).

Pursuant to the authorization of the Board of Directors of Harvard Bioscience, Inc. in accordance with Section 17 of the Plan, the Plan is hereby amended as follows, effective as of the Effective Date:

	  	
1.

	
Clause (v) of Section 3(b) of the Plan is hereby deleted in its entirety and replaced with the following in its stead:

 

“(v) the price for each share subject to any then outstanding Stock Options and Stock Appreciation Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of Stock Options and Stock Appreciation Rights) as to which such Stock Options and Stock Appreciation Rights remain exercisable in a manner that will trigger tax under Section 409A”

	  	
2.

	
Section 4 of the Plan is hereby amended by adding the following provisions to the end thereof:

 

“With respect to the Awards (“Adjustment Awards”) modified or issued in connection with any equitable adjustment by the Company, in accordance herewith and with the formulas and provisions set forth in the Separation and Distribution Agreement that may be entered into by and between the Company and Harvard Apparatus Regenerative Technology, Inc. (“HART”), of certain Awards previously granted by the Company, notwithstanding any other provision of the Plan or Award to the contrary, for purposes of exercisability, vesting and the post-termination exercise periods applicable to any Awards, continued employment with, or service to, the Company (or its subsidiaries) or HART (or its subsidiaries) is considered to be continued employment with, and service to, the other, provided that the failure to exercise Incentive Stock Options within the applicable deadline following any separation from service from the Company shall cause such options to be treated thereafter as Non-Qualified Stock Options.”

	  	
3.

	
The following is added to the end of the Plan:

 

“DATE FIRST AMENDMENT TO HARVARD BIOSCIENCE, INC. THIRD AMENDED AND RESTATED 2000 STOCK OPTION AND INCENTIVE PLAN APPROVED BY BOARD OF DIRECTORS: MARCH 9, 2013.”

	  	
4.

	
Except as expressly amended hereby, the Plan shall remain in full force and effect.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}]]